{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Genzyme", "item": "https://www.patentleaderboard.com/company/genzyme"}, {"@type": "ListItem", "position": 3, "name": "Matthew Adamowicz", "item": "https://www.patentleaderboard.com/inventor/fl:ma_ln:adamowicz-3"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MA

Matthew Adamowicz — 3 Patents

GEGenzyme: 3 patents #229 of 891Top 30%
Bound Brook Junction, NJ: #101 of 213 inventorsTop 50%
New Jersey: #23,671 of 69,400 inventorsTop 35%
Overall (All Time): #1,328,092 of 4,157,543Top 35%
3 Patents All Time
Matthew Adamowicz has been granted 3 US patents while listed as an inventor at Genzyme. The first was granted in 2019 and the most recent in January 2025. Matthew Adamowicz ranks #1,328,092 of 4,157,543 US inventors in our database (top 31.9%). Patent records list Matthew Adamowicz in Bound Brook Junction, NJ, US.

Patents per Year

Patents granted per year, 2019 to 2025Bar chart with a peak of 1 patents in 2019.peak 12019: 1 patents20192021: 1 patents20212025: 1 patents2025

Issued Patents All Time

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
12201698 Gene therapy for retinitis pigmentosa Catherine R. O'Riordan 2025-01-21
11103598 Gene therapy for retinitis pigmentosa Catherine R. O'Riordan 2021-08-31
10383953 Gene therapy for retinitis pigmentosa Catherine R. O'Riordan 2019-08-20